×
More Charts Below
Cresco Labs Goodwill and Intangible Assets 2020-2024 | CRLBF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Recent Trends
Cresco Labs goodwill and intangible assets from 2020 to 2024. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Quarterly Chart
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$227.2B
Boston Scientific (BSX)
$140.7B
Stryker (SYK)
$132.3B
EssilorLuxottica (ESLOY)
$128.4B
Medtronic (MDT)
$105.9B
Lonza Group Ag (LZAGY)
$47.4B
Haleon (HLN)
$46.2B
ResMed (RMD)
$31.3B
Agilent Technologies (A)
$29.2B
GE HealthCare Technologies (GEHC)
$28.6B
Terumo (TRUMY)
$28.2B
Koninklijke Philips (PHG)
$22.2B
Zimmer Biomet Holdings (ZBH)
$19.4B
Insulet (PODD)
$17.3B
Baxter (BAX)
$14.8B
Smith & Nephew SNATS (SNN)
$11.4B
Sunny Optical Technology (SNPTF)
$7.6B
Lantheus Holdings (LNTH)
$6.9B
Bio-Rad Laboratories (BIO)
$6.7B
Demant (WILYY)
$6.6B
Prestige Consumer Healthcare (PBH)
$4B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
Perrigo (PRGO)
$3.5B
ICU Medical (ICUI)
$3.4B
Haemonetics (HAE)
$2.9B
Envista Holdings (NVST)
$2.6B
GN Store Nord (GNNDY)
$2.2B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.7B
AtriCure (ATRC)
$1.6B